CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-08 | Lea Darrell Shane Chief Commercial Officer | Grant or award | +39,599 | 39,599 | ||
| 2023-12-08 | Kolean Chad J Chief Financial Officer | Grant or award | +42,554 | 42,578 | ||
| 2023-12-08 | Shustov Andrei Senior Vice President, Medical | Grant or award | +47,856 | 55,037.7 | ||
| 2023-12-08 | Longcor Jarrod Chief Operating Officer | Grant or award | +42,927 | 53,141 | ||
| 2023-12-08 | CARUSO JAMES V President and CEO | Grant or award | +40,596 | 49,236 | ||
| 2023-06-28 | Swirsky Douglas J Director | Grant or award · Stock option (right to buy) | +37,500 | 71,925 | ||
| 2023-06-28 | NEIS JOHN Director | Grant or award · Stock option (right to buy) | +25,000 | 47,887 | ||
| 2023-06-28 | Loren Stefan Director | Grant or award · Stock option (right to buy) | +25,000 | 47,885 | ||
| 2023-06-28 | DRISCOLL FREDERICK W Director | Grant or award · Stock option (right to buy) | +25,000 | 47,650 | ||
| 2023-06-28 | Chanan-Khan Asher Director | Grant or award · Stock option (right to buy) | +25,000 | 40,600 | ||
| 2023-06-23 | Lea Darrell Shane Chief Commercial Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2023-06-23 | Kolean Chad J Chief Financial Officer | Grant or award · Stock option (right to buy) | +104,000 | 104,000 | ||
| 2023-06-23 | Longcor Jarrod Chief Operating Officer | Grant or award · Stock option (right to buy) | +144,000 | 144,000 | ||
| 2023-06-23 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +261,000 | 261,000 | ||
| 2023-02-15 | Shustov Andrei Senior Vice President, Medical | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2023-01-17 | Longcor Jarrod Chief Operating Officer | Grant or award · Stock option (right to buy) | +144,000 | 144,000 | ||
| 2023-01-17 | CARUSO JAMES V President and CEO | Grant or award · Stock option (right to buy) | +261,000 | 261,000 | ||
| 2023-01-17 | Kolean Chad J Chief Financial Officer | Grant or award · Stock option (right to buy) | +104,000 | 104,000 | ||
| 2022-11-21 | Lea Darrell Shane Chief Commercial Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-24 | Swirsky Douglas J Director | Grant or award · Stock option (right to buy) | +11,700 | 11,700 |
Page 3 of 6 · 117 trades